Adjuvant Therapy of Resected Non-small Cell Lung Cancer: can We Move Forward?
Curr Treat Options Oncol
; 17(10): 54, 2016 10.
Article
en En
| MEDLINE
| ID: mdl-27523606
Palabras clave
Adjuvant treatment; Afatinib; Anti-angiogenic drugs; Atezolizumab; BRCA1; Bevacizumab; Crizotinib; Durvalumab; ERCC1; Early stage; Erlotinib; Gefitinib; ITACA trial; Immunotherapy; MAGE-A3; NSCLC; Nivolumab; Non-small cell lung cancer; Pembrolizumab; Predictive biomarkers; RRM1; TKIs; TS; Tyrosine kinase inhibitors
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Carcinoma de Pulmón de Células no Pequeñas
/
Neoplasias Pulmonares
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
/
Systematic_reviews
Límite:
Humans
Idioma:
En
Año:
2016
Tipo del documento:
Article